Shiyao Group’s acquisition of “myocardial infarction life-saving needle” behind: The impact of enbipu patent expiration?

Zhongxin Jingwei February 15 (Wang Yuling Yan Shuxin) recently, Shiyao Group announced that it has completed the acquisition of 100% rights and interests of Zhuhai Zhifan from an independent third party, which owns 51% shares of Guangzhou Mingkang Biological Engineering Co., LTD. (hereinafter referred to as Mingkang Biological), and will inject 154 million yuan.It is… Read more Shiyao Group’s acquisition of “myocardial infarction life-saving needle” behind: The impact of enbipu patent expiration?